UroGen Pharma (URGN) Return on Capital Employed [ROCE] (2018 - 2026)
UroGen Pharma (URGN) posted Return on Capital Employed [ROCE] of -34.86% for Q2 2026, up 33.56 percentage points from -68.41% a year earlier and up 26.48 percentage points from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends
For FY2025, UroGen Pharma's Return on Capital Employed [ROCE] came in at -63.49%, down 11.47 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +26.55 percentage points (FY2020 to FY2025).
- In prior years, UroGen Pharma's Return on Capital Employed [ROCE] was -52.02% in FY2024 (+0.10 pp), -52.11% in FY2023 (+24.06 pp), -76.17% in FY2022 (+17.53 pp) and -93.70% in FY2021 (-3.66 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -10.56 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2024, with a gain of 59.44 percentage points; the weakest was Q3 2025, with a drop of 53.95 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -61.33% (Q1 2026), -85.33% (Q4 2025) and -86.27% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | -34.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.86% |
| Mar 31, 2026 | -61.33% |
| Dec 31, 2025 | -85.33% |
| Sep 30, 2025 | -86.27% |
| Jun 30, 2025 | -68.41% |
| Mar 31, 2025 | -48.05% |
| Dec 31, 2024 | -39.04% |
| Sep 30, 2024 | -32.32% |
| Jun 30, 2024 | -38.50% |
| Mar 31, 2024 | -42.45% |
| Dec 31, 2023 | -42.35% |
| Sep 30, 2023 | -59.99% |
| Jun 30, 2023 | -97.94% |
| Mar 31, 2023 | -79.89% |
| Dec 31, 2022 | -73.10% |
| Sep 30, 2022 | -66.50% |
| Jun 30, 2022 | -60.94% |
| Mar 31, 2022 | -71.28% |
| Dec 31, 2021 | -88.07% |
| Sep 30, 2021 | -80.10% |
API Access
UroGen Pharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();